FABP5 and breast cancer: Relapse-free survival (%RFS) indicated that FABP4 (p = 0.015) and FABP5 expression (p = 0.075) correlated with TNBC occurrence and decreased survival, but not in hormone positive mammary tumors (Figure 1b).